These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 25855398)
1. Lethal arrhythmia due to fingolimod, a S1P receptor modulator: are we overestimating or underestimating? Mori M J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):823. PubMed ID: 25855398 [No Abstract] [Full Text] [Related]
3. Fingolimod treatment for multiple sclerosis patients What do we do with varicella? Winkelmann A; Loebermann M; Reisinger EC; Hartung HP; Zettl UK Ann Neurol; 2011 Oct; 70(4):673-4; author reply 674. PubMed ID: 22028236 [No Abstract] [Full Text] [Related]
5. Oral fingolimod to treat multiple sclerosis: see your cardiologist first. Sato DK; Callegaro D Arq Neuropsiquiatr; 2014 Sep; 72(9):651-2. PubMed ID: 25252227 [No Abstract] [Full Text] [Related]
6. [A plan for risk management in the treatment of multiple sclerosis with gilenia (fingolimod)]. Popova NF Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):110-3. PubMed ID: 21916166 [No Abstract] [Full Text] [Related]
7. Melanoma occurring during treatment with fingolimod for multiple sclerosis: a case report. Conzett KB; Kolm I; Jelcic I; Kamarachev J; Dummer R; Braun R; French LE; Linnebank M; Hofbauer GF Arch Dermatol; 2011 Aug; 147(8):991-2. PubMed ID: 21844470 [No Abstract] [Full Text] [Related]
8. Delayed fingolimod-associated asystole. Espinosa PS; Berger JR Mult Scler; 2011 Nov; 17(11):1387-9. PubMed ID: 21652609 [TBL] [Abstract][Full Text] [Related]
9. Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient. Lysandropoulos AP; Benghiat F Mult Scler; 2013 Oct; 19(11):1551-2. PubMed ID: 23817558 [No Abstract] [Full Text] [Related]
11. The pill times 2: what every woman with multiple sclerosis should know. Langer-Gould AM Neurology; 2014 Feb; 82(8):654-5. PubMed ID: 24463629 [No Abstract] [Full Text] [Related]
12. Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment. Rolf L; Muris AH; Damoiseaux J; van Daele M; Hupperts R Neurology; 2014 Mar; 82(11):1008-9. PubMed ID: 24523479 [No Abstract] [Full Text] [Related]
13. Branch retinal vein occlusion during fingolimod treatment in a patient with multiple sclerosis. Gallego-Pinazo R; España-Gregori E; Casanova B; Pardo-López D; Díaz-Llopis M J Neuroophthalmol; 2011 Sep; 31(3):292-3. PubMed ID: 21826025 [No Abstract] [Full Text] [Related]
14. Fingolimod for multiple sclerosis. Pelletier D; Hafler DA N Engl J Med; 2012 Jan; 366(4):339-47. PubMed ID: 22276823 [No Abstract] [Full Text] [Related]
15. Cystoid macular edema associated with fingolimod use for multiple sclerosis. Afshar AR; Fernandes JK; Patel RD; Ksiazek SM; Sheth VS; Reder AT; Hariprasad SM JAMA Ophthalmol; 2013 Jan; 131(1):103-7. PubMed ID: 23307220 [No Abstract] [Full Text] [Related]
16. Oral fingolimod (gilenya) for multiple sclerosis. Med Lett Drugs Ther; 2010 Dec; 52(1353-1354):98-9. PubMed ID: 21344782 [No Abstract] [Full Text] [Related]
17. Multiple sclerosis: Study reinforces need for contraception in women taking fingolimod. Jones B Nat Rev Neurol; 2014 Mar; 10(3):125. PubMed ID: 24514867 [No Abstract] [Full Text] [Related]
18. New drugs may improve, complicate treatment for multiple sclerosis. Link H; Martin R Nat Med; 2010 Mar; 16(3):272. PubMed ID: 20208513 [No Abstract] [Full Text] [Related]
19. [New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimod]. Komoly S Ideggyogy Sz; 2012 Nov; 65(11-12):421-2. PubMed ID: 23289178 [No Abstract] [Full Text] [Related]
20. Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod. Gross CM; Baumgartner A; Rauer S; Stich O Neurology; 2012 Nov; 79(19):2006-7. PubMed ID: 23035074 [No Abstract] [Full Text] [Related] [Next] [New Search]